307
Views
9
CrossRef citations to date
0
Altmetric
Articles

Patients with type 2 diabetes and difficulties associated with initiation of insulin therapy in a public health clinic in Durban

, MBChB (Medical Officer) & , MBChB, MFamMed, FCFP, MSc, DipHIVMan, DipPEC (Head Clinical Unit and Lecturer)
Pages 436-440 | Received 28 Oct 2011, Accepted 23 Mar 2012, Published online: 15 Aug 2014

References

  • Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053.
  • Motala AA, Pirie FJ, Gouws E, et al. High incidence of type 2 diabetes mellitus in South African Indians: a 10-year follow-up study. Diabet Med. 2003;20(1):23–30.
  • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853.
  • Fu AZ, Qiu Y, Radican L. Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Curr Med Res Opin. 2009;25(6):1413–1420.
  • Haque M, Emerson S, Dennison C. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. S Afr Med J. 2005;95(10):798–802.
  • Polonsky WH, Fisher L, Guzman S, et al. Psychological insulin resistance in patients with type 2 diabetes. Diabetes Care. 2005;28(10):2543–2545.
  • Alberti G. The DAWN (Diabetes, Attitudes, Wishes and Needs) study. Practical Diabetes International. 2002;19:22–24.
  • Tan N, Tan A, Yeo J. RETHINK: an observational cross sectional study on the uptake of insulin therapy among type 2 diabetes patients with secondary drug failure treated in primary care. Asia Pacific Family Medicine. 2003;2:157–165.
  • New survey explores the impact of insulin injections. Injection Impact Report [homepage on the Internet]. 2008. Available from: http://www.injectionimpact.com
  • Khan H, Lasker SS, Chowdhury TA. Prevalence and reasons for insulin refusal in Bangladeshi patients with poorly controlled type 2 diabetes in East London. Diabet Med. 2008;25(9):1108–1111.
  • Meece J. Overcoming barriers to insulin therapy. Pharmacy Times [homepage on the Internet]. 2008. Available from: http://www.pharmacytimes.com/publications/issue/2008/2008-10/2008-10-8703
  • National Department of Health. Standard treatment guidelines and essential medicines list. National Department of Health, 2008; p.156–157.
  • Watanabi K, Kurose T, Kitatani N, et al. The role of family nutritional support in Japanese patients with type 2 diabetes mellitus. Intern Med. 2010;49(11):983–989.
  • Brown K, Avis M, Hubbard M. Health beliefs of African-Caribbean people with type 2 diabetes: a qualitative study. Br J Gen Pract. 2007;57(539):461–469.
  • Alazri MH, Neal RD, Heywood P, Leese B. Patients' experiences of continuity in the care of type 2 diabetes: a focus group study in primary care. Br J Gen Pract. 2006;56(528):488–495.
  • SEMDSA guidelines for the diagnosis and management of type 2 diabetes mellitus for primary health care 2009. JEMDSA. 2009;14(1):55–58.
  • Halpern SD, Karlawish JHT, Berlin JA. The continuing unethical conduct of underpowered clinical trials. JAMA. 2002;288(3):358–362.